It also leads to strong induction of multi-drug resistance 1 (MDR1) for acquired chemo-resistance, as chemotherapy further enhances RelA activation for MDR1 transcription in PDLIM2 deficient tumor cells (Sun et al., 2019). Here, PDLIM2 is linked to neoplasm.